在移植接受者中解决CMV问题:过去,现在和未来
Tal Schlaeffer-Yosef1, Lior Nesher2
1Infectious Diseases Institute, Soroka University Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 1 Rager Street, 84101, Beer-Sheva, Israel.
Infectious diseases and therapy
|April 27, 2025
概括
细胞巨乳病毒 (CMV) 对移植接受者构成风险. 莱特莫维尔和马里巴维尔等新策略改善了预防和治疗,而免疫监测可以个性化护理并减少药物暴露.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 细胞巨乳病毒 (CMV) 是一种终身潜伏的β-疹病毒,对移植受体具有重大风险.
- 管理已经从反应性转向主动性,预防性策略,以减轻CMV相关的发病率和死亡率.
研究的目的:
- 审查最近在CMV预防和移植接受者治疗方面的进展.
- 讨论新型药物的作用,如莱特莫维尔和马里巴维尔.
- 探索免疫监测对个性化预防策略的潜力.
主要方法:
- 关于移植中CMV预防和治疗的当前文献的综述.
- 对莱特莫维尔和马里巴维尔的疗效和安全性分析.
- 讨论新兴的诊断工具,包括干扰素-释放试验.
主要成果:
- 莱特莫维尔和马里巴维尔分别代表着CMV预防和治疗的重大进展.
- 晚期发生的CMV感染后预防仍然是一个挑战.
- 免疫监测试验在指导预防决策方面表现有前途.
结论:
- 新型抗病毒药物和基于免疫的诊断正在改变移植接受者的CMV管理.
- 基于免疫能力的个性化方法是CMV护理的未来.
- 持续创新对于减少CMV并发症和改善移植结果至关重要.
关键词:
进行骨髓移植.细胞巨乳病毒病毒.甘西克洛维尔 (Ganciclovir) 是一种天然的药物.干扰素玛释放量测定试验这就是Letermovir.玛丽巴维尔 (Maribavir) 是一个实体器官移植器官移植是什么更多相关视频
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
12.4K
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
12.7K
相关概念视频
Bone Marrow Sampling and Transplants
316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316
Tissue Transplantation
346
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
346
